Medicare Benefits Schedule - Item 73302

Characterisation of germline gene variants including copy number variants, in BRCA1 or BRCA2 genes, in a patient who has had a pathogenic or likely pathogenic variant identified in either gene by tumour testing and who has not previously received a service to which items 73295, 73296 or 73297 applies, requested by a specialist or consultant physician.

Applicable once per primary tumour diagnosis

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

• Previous - Item 73301
• Next - Item 73303